This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Intuitive Surgical, Inc. (ISRG) Stock Sinks As Market Gains: Here's Why
by Zacks Equity Research
In the most recent trading session, Intuitive Surgical, Inc. (ISRG) closed at $422.90, indicating a -1.21% shift from the previous trading day.
Intuitive Surgical, Inc. (ISRG) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
Recently, Zacks.com users have been paying close attention to Intuitive Surgical (ISRG). This makes it worthwhile to examine what the stock has in store.
Wall Street Analysts Think Intuitive Surgical (ISRG) Is a Good Investment: Is It?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Intuitive Surgical (ISRG). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
Reasons to Retain Intuitive Surgical (ISRG) in Your Portfolio
by Zacks Equity Research
Intuitive Surgical (ISRG) continues to raise optimism among investors owing to its strength in robotics.
Intuitive Surgical (ISRG) Gets FDA Nod for da Vinci's New Label
by Zacks Equity Research
Intuitive Surgical (ISRG) announces the FDA clearance of revised da Vinci Xi and X Labeling on Radical Prostatectomy.
Intuitive Surgical, Inc. (ISRG) Increases Despite Market Slip: Here's What You Need to Know
by Zacks Equity Research
Intuitive Surgical, Inc. (ISRG) reachead $418.15 at the closing of the latest trading day, reflecting a +0.22% change compared to its last close.
Should You Invest in the iShares U.S. Medical Devices ETF (IHI)?
by Zacks Equity Research
Sector ETF report for IHI
Intuitive Surgical, Inc. (ISRG) Increases Despite Market Slip: Here's What You Need to Know
by Zacks Equity Research
The latest trading day saw Intuitive Surgical, Inc. (ISRG) settling at $403.39, representing a +1.25% change from its previous close.
Intuitive Surgical, Inc. (ISRG) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
Intuitive Surgical (ISRG) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Intuitive Surgical (ISRG) Stock Gains 20% YTD: Here's Why
by Zacks Equity Research
Intuitive Surgical (ISRG) shares gain on the back of growth in the da Vinci treatment volume and raised procedure prices.
Intuitive Surgical, Inc. (ISRG) Exceeds Market Returns: Some Facts to Consider
by Zacks Equity Research
Intuitive Surgical, Inc. (ISRG) concluded the recent trading session at $404.85, signifying a +1.62% move from its prior day's close.
Thermo Fisher (TMO) Up 2.3% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Thermo Fisher (TMO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Is It Worth Investing in Intuitive Surgical (ISRG) Based on Wall Street's Bullish Views?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Intuitive Surgical (ISRG) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
Intuitive Surgical (ISRG) Hits 52-Week High on Procedure Demand
by Zacks Equity Research
Intuitive Surgical's (ISRG) da Vinci procedure volume, coupled with strong Ion procedure growth, is fueling the rally in the company???s share price.
Reasons to Retain Intuitive Surgical (ISRG) in Your Portfolio
by Zacks Equity Research
Intuitive Surgical (ISRG) continues to raise optimism among investors, owing to its strength in robotics.
The Zacks Analyst Blog Highlights Stocks recently featured in the blog include: The Procter & Gamble, Verizon Communications, Intuitive Surgical, Norfolk Southern and The Allstate
by Zacks Equity Research
The Procter & Gamble, Verizon Communications, Intuitive Surgical, Norfolk Southern and The Allstate are included in this Analyst Blog.
Top Research Reports for Procter & Gamble, Verizon & Intuitive Surgical
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including The Procter & Gamble Company (PG), Verizon Communications Inc. (VZ) and Intuitive Surgical, Inc. (ISRG).
Here is What to Know Beyond Why Intuitive Surgical, Inc. (ISRG) is a Trending Stock
by Zacks Equity Research
Intuitive Surgical (ISRG) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Intuitive Surgical, Inc. (ISRG) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
Recently, Zacks.com users have been paying close attention to Intuitive Surgical (ISRG). This makes it worthwhile to examine what the stock has in store.
Intuitive Surgical (ISRG) Q1 Earnings Beat, Procedures Robust
by Zacks Equity Research
Intuitive Surgical's (ISRG) first-quarter results reflect a healthy demand for procedures. Higher pricing boosts procedure sales. An improvement in margins buoys well.
Intuitive Surgical (ISRG) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
by Zacks Equity Research
The headline numbers for Intuitive Surgical (ISRG) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Big Q1 Beats After the Close; Markets Struggle to Gain
by Mark Vickery
Netflix, Taiwan Semi and Intuitive Surgical all handily beat Q1 estimates, but only one is trading in the green this afternoon.
Intuitive Surgical, Inc. (ISRG) Q1 Earnings and Revenues Top Estimates
by Zacks Equity Research
Intuitive Surgical (ISRG) delivered earnings and revenue surprises of 7.14% and 1.39%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Big-Picture Investing as Q1 Earnings Loom: Stocks to Watch
by Bryan Hayes
The earnings slate is set to heat up in the coming days.
Don't Miss These 5 Earnings Charts
by Tracey Ryniec
These are the stocks everyone should be watching this week.